Heterogeneous clinical features in Cockayne syndrome patients and siblings carrying the same CSA mutations.
CSA
Clinical heterogeneity
Cockayne syndrome
ERCC8
Siblings
Targeted gene sequencing
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
05 03 2022
05 03 2022
Historique:
received:
01
06
2021
accepted:
16
02
2022
entrez:
6
3
2022
pubmed:
7
3
2022
medline:
14
4
2022
Statut:
epublish
Résumé
Cockayne syndrome (CS) is a rare autosomal recessive disorder caused by mutations in ERCC6/CSB or ERCC8/CSA that participate in the transcription-coupled nucleotide excision repair (TC-NER) of UV-induced DNA damage. CS patients display a large heterogeneity of clinical symptoms and severities, the reason of which is not fully understood, and that cannot be anticipated in the diagnostic phase. In addition, little data is available for affected siblings, and this disease is largely undiagnosed in North Africa. We report here the clinical description as well as genetic and functional characterization of eight Tunisian CS patients, including siblings. These patients, who belonged to six unrelated families, underwent complete clinical examination and biochemical analyses. Sanger sequencing was performed for the recurrent mutation in five families, and targeted gene sequencing was done for one patient of the sixth family. We also performed Recovery RNA Synthesis (RRS) to confirm the functional impairment of DNA repair in patient-derived fibroblasts. Six out of eight patients carried a homozygous indel mutation (c.598_600delinsAA) in exon 7 of ERCC8, and displayed a variable clinical spectrum including between siblings sharing the same mutation. The other two patients were siblings who carried a homozygous splice-site variant in ERCC8 (c.843+1G>C). This last pair presented more severe clinical manifestations, which are rarely associated with CSA mutations, leading to gastrostomy and hepatic damage. Impaired TC-NER was confirmed by RRS in six tested patients. This study provides the first deep characterization of case series of CS patients carrying CSA mutations in North Africa. These mutations have been described only in this region and in the Middle-East. We also provide the largest characterization of multiple unrelated patients, as well as siblings, carrying the same mutation, providing a framework for dissecting elusive genotype-phenotype correlations in CS.
Sections du résumé
BACKGROUND
Cockayne syndrome (CS) is a rare autosomal recessive disorder caused by mutations in ERCC6/CSB or ERCC8/CSA that participate in the transcription-coupled nucleotide excision repair (TC-NER) of UV-induced DNA damage. CS patients display a large heterogeneity of clinical symptoms and severities, the reason of which is not fully understood, and that cannot be anticipated in the diagnostic phase. In addition, little data is available for affected siblings, and this disease is largely undiagnosed in North Africa.
METHODS
We report here the clinical description as well as genetic and functional characterization of eight Tunisian CS patients, including siblings. These patients, who belonged to six unrelated families, underwent complete clinical examination and biochemical analyses. Sanger sequencing was performed for the recurrent mutation in five families, and targeted gene sequencing was done for one patient of the sixth family. We also performed Recovery RNA Synthesis (RRS) to confirm the functional impairment of DNA repair in patient-derived fibroblasts.
RESULTS
Six out of eight patients carried a homozygous indel mutation (c.598_600delinsAA) in exon 7 of ERCC8, and displayed a variable clinical spectrum including between siblings sharing the same mutation. The other two patients were siblings who carried a homozygous splice-site variant in ERCC8 (c.843+1G>C). This last pair presented more severe clinical manifestations, which are rarely associated with CSA mutations, leading to gastrostomy and hepatic damage. Impaired TC-NER was confirmed by RRS in six tested patients.
CONCLUSIONS
This study provides the first deep characterization of case series of CS patients carrying CSA mutations in North Africa. These mutations have been described only in this region and in the Middle-East. We also provide the largest characterization of multiple unrelated patients, as well as siblings, carrying the same mutation, providing a framework for dissecting elusive genotype-phenotype correlations in CS.
Identifiants
pubmed: 35248096
doi: 10.1186/s13023-022-02257-1
pii: 10.1186/s13023-022-02257-1
pmc: PMC8898519
doi:
Substances chimiques
ERCC8 protein, human
0
Poly-ADP-Ribose Binding Proteins
0
Transcription Factors
0
DNA Repair Enzymes
EC 6.5.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
121Informations de copyright
© 2022. The Author(s).
Références
J Child Neurol. 2006 Apr;21(4):333-7
pubmed: 16900932
Sci Rep. 2017 Oct 20;7(1):13686
pubmed: 29057985
Ageing Res Rev. 2017 Jan;33:3-17
pubmed: 27507608
Genet Med. 2016 May;18(5):483-93
pubmed: 26204423
Arch Pediatr. 2017 Apr;24(4):353-359
pubmed: 28258862
Ann Hum Genet. 2015 Nov;79(6):402-17
pubmed: 26420437
Tunis Med. 2009 Dec;87(12):877-9
pubmed: 20209858
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6209-14
pubmed: 19329487
DNA Repair (Amst). 2015 Dec;36:13-18
pubmed: 26388429
Am J Med Genet A. 2010 Dec;152A(12):3091-4
pubmed: 21108394
DNA Repair (Amst). 2008 May 3;7(5):744-50
pubmed: 18329345
Mech Ageing Dev. 2013 May-Jun;134(5-6):202-11
pubmed: 23422418
Cell. 2011 Nov 23;147(5):1024-39
pubmed: 22118460
Genes (Basel). 2021 Nov 29;12(12):
pubmed: 34946871
Mech Ageing Dev. 2013 May-Jun;134(5-6):261-9
pubmed: 23562424
Orphanet J Rare Dis. 2016 Mar 22;11:26
pubmed: 27004399
Front Genet. 2019 Feb 14;10:111
pubmed: 30838033
Am J Hum Genet. 1978 Nov;30(6):590-601
pubmed: 747187
Mech Ageing Dev. 2013 May-Jun;134(5-6):161-70
pubmed: 23428416
Am J Med Genet A. 2011 May;155A(5):1081-95
pubmed: 21480477
Mech Ageing Dev. 2013 May-Jun;134(5-6):196-201
pubmed: 23571135
J Med Genet. 2018 May;55(5):329-343
pubmed: 29572252
Nat Protoc. 2015 Jan;10(1):12-24
pubmed: 25474029
Biotechniques. 1998 Oct;25(4):630-2, 634, 636 passim
pubmed: 9793645
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Mech Ageing Dev. 2013 May-Jun;134(5-6):275-83
pubmed: 23435289
Cancer Res. 1982 Apr;42(4):1473-8
pubmed: 6174225
Iran J Kidney Dis. 2017 May;11(3):253-255
pubmed: 28575888
Tunis Med. 2005 Dec;83(12):760-3
pubmed: 16450945
Hum Mol Genet. 1999 May;8(5):935-41
pubmed: 10196384
Am J Med Genet. 1992 Jan 1;42(1):68-84
pubmed: 1308368
Cell. 2003 May 2;113(3):357-67
pubmed: 12732143
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:155-179
pubmed: 31039041
Cells. 2019 Jan 25;8(2):
pubmed: 30691039
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
DNA Repair (Amst). 2010 May 4;9(5):506-16
pubmed: 20171149
BMC Med Genet. 2018 Sep 10;19(1):161
pubmed: 30200888
Genet Med. 2008 Dec;10(12):903-9
pubmed: 19092443
Orphanet J Rare Dis. 2021 Feb 3;16(1):63
pubmed: 33536051
PLoS Biol. 2006 Jun;4(6):e203
pubmed: 16752948
NPJ Genom Med. 2021 Jul 15;6(1):60
pubmed: 34267211
Nucleic Acids Res. 2020 Mar 18;48(5):2473-2485
pubmed: 31970402
Orphanet J Rare Dis. 2017 Apr 4;12(1):65
pubmed: 28376890
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2910-9
pubmed: 26038566
Pediatrics. 1977 Aug;60(2):135-9
pubmed: 887325
Hum Mutat. 2010 Feb;31(2):113-26
pubmed: 19894250
Eur J Hum Genet. 2018 Apr;26(4):527-536
pubmed: 29422660
Genet Mol Biol. 2020 May 20;43(1 suppl. 1):e20190085
pubmed: 32453336